264 related articles for article (PubMed ID: 31368838)
1. Venlafaxine pharmacogenetics: a comprehensive review.
Suwała J; Machowska M; Wiela-Hojeńska A
Pharmacogenomics; 2019 Jul; 20(11):829-845. PubMed ID: 31368838
[TBL] [Abstract][Full Text] [Related]
2. Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial).
Berm EJ; Hak E; Postma M; Boshuisen M; Breuning L; Brouwers JR; Dhondt T; Jansen PA; Kok RM; Maring JG; van Marum R; Mulder H; Voshaar RC; Risselada AJ; Venema H; Vleugel L; Wilffert B
Trials; 2015 Jan; 16():37. PubMed ID: 25636328
[TBL] [Abstract][Full Text] [Related]
3. Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?
Taranu A; Colle R; Gressier F; El Asmar K; Becquemont L; Corruble E; Verstuyft C
Pharmacogenomics; 2017 May; 18(7):639-650. PubMed ID: 28480819
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine.
Nassan M; Nicholson WT; Elliott MA; Rohrer Vitek CR; Black JL; Frye MA
Mayo Clin Proc; 2016 Jul; 91(7):897-907. PubMed ID: 27289413
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2D6 on venlafaxine metabolism in Trinidadian patients with major depressive disorder.
Montané Jaime LK; Paul J; Lalla A; Legall G; Gaedigk A
Pharmacogenomics; 2018 Feb; 19(3):197-212. PubMed ID: 29327975
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.
Whyte EM; Romkes M; Mulsant BH; Kirshne MA; Begley AE; Reynolds CF; Pollock BG
Int J Geriatr Psychiatry; 2006 Jun; 21(6):542-9. PubMed ID: 16642541
[TBL] [Abstract][Full Text] [Related]
8. Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry.
Berm E; Kok R; Hak E; Wilffert B
Pharmacopsychiatry; 2016 Sep; 49(5):186-190. PubMed ID: 27101231
[No Abstract] [Full Text] [Related]
9. Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions.
Marshe VS; Islam F; Maciukiewicz M; Bousman C; Eyre HA; Lavretsky H; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
Am J Geriatr Psychiatry; 2020 Jun; 28(6):609-629. PubMed ID: 32122803
[TBL] [Abstract][Full Text] [Related]
10. Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial).
van der Schans J; Hak E; Postma M; Breuning L; Brouwers JRBJ; Ditters K; Jansen PAF; Kok RM; Maring JG; van Marum R; Mulder H; Nanninga J; Oude Voshaar RC; Risselada AJ; Vleugel L; Stek M; van Schaik RHN; Berm EJJ; Wilffert B
J Clin Psychopharmacol; 2019; 39(6):583-590. PubMed ID: 31688392
[TBL] [Abstract][Full Text] [Related]
11. Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors.
Gressier F; Verstuyft C; Hardy P; Becquemont L; Corruble E
J Neural Transm (Vienna); 2015 Jan; 122(1):35-42. PubMed ID: 25047911
[TBL] [Abstract][Full Text] [Related]
12. Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
Castanares-Zapatero D; Gillard N; Capron A; Haufroid V; Hantson P
Forensic Sci Int; 2016 Sep; 266():e48-e51. PubMed ID: 27328779
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report.
Del Toro-Pagán NM; Matos A; Bardolia C; Michaud V; Turgeon J; Amin NS
BMC Psychiatry; 2022 Jan; 22(1):46. PubMed ID: 35057765
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
Ciusani E; Zullino DF; Eap CB; Brawand-Amey M; Brocard M; Baumann P
J Psychopharmacol; 2004 Dec; 18(4):559-66. PubMed ID: 15582923
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
Henry NL; Stearns V; Flockhart DA; Hayes DF; Riba M
Am J Psychiatry; 2008 Oct; 165(10):1251-5. PubMed ID: 18829880
[No Abstract] [Full Text] [Related]
16. Antidepressant pharmacogenetics in children and young adults: A systematic review.
Maruf AA; Greenslade A; Arnold PD; Bousman C
J Affect Disord; 2019 Jul; 254():98-108. PubMed ID: 31112844
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic studies: a tool to improve antidepressant therapy.
Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
[TBL] [Abstract][Full Text] [Related]
18. Influence of CYP2D6 and CYP2C19 genotypes on venlafaxine metabolic ratios and stereoselective metabolism in forensic autopsy cases.
Karlsson L; Zackrisson AL; Josefsson M; Carlsson B; Green H; Kugelberg FC
Pharmacogenomics J; 2015 Apr; 15(2):165-71. PubMed ID: 25245581
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.
Volon B; Willemart T; Haufroid V; Hantson P
Prim Care Companion CNS Disord; 2019 Nov; 21(6):. PubMed ID: 31794166
[No Abstract] [Full Text] [Related]
20. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
